4D Molecular Therapeutics (FDMT) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.01
-0.92
-0.82
-0.73

Details

Expected EPS
-0.995556
Actual EPS
-1.01
Surprise EPS
-0.01
Surprise Percent
-1.45%

Description

⁨4D Molecular Therapeutics⁩ (⁦FDMT⁩) has reported earnings of ⁦-1.01⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts